Progenics Pharmaceuticals Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Pharmacyclics.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 1998 | Founding Date 1991 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Sunnyvale, US HQ |
Employees | Employees 373157% increase | Employees 6551% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods $228.8m (FY, 2025) | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit $1.2b (FY, 2025) | Gross profit $689.3m (FY, 2014) |
Net income | Net income $316.9m (FY, 2025) | Net income $86.1m (FY, 2014) |
For sources of this data, please see the company profile
View Company Profiles
Pharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company